-
Document de presse | 2016.11.08
The ADITEC Project on Advanced Immunization Technologies: an European Success Story
30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications, and...
-
Page avancée | 2016.03.29
Medical Center
The Institut Pasteur Medical Center is a health center open to the public. Family and specialist physicians offer a range of services geared towards those traveling abroad (vaccinations and travel medicine) and patients suffering from infectious and tropical diseases, and allergies (diagnosis and treatment).
-
News | 2016.06.22
Antibodies that are effective against both dengue and Zika viruses
Scientists have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal vaccine that offers simultaneous protection against dengue and Zika virus disease.
-
News | 2015.02.02
Moderna and Institut Pasteur Sign Strategic Research Collaboration
Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.
-
News | 2014.06.09
Immunological memory discovered in fetuses
Scientists have recently demonstrated the existence of immunological memory cells in fetuses. These cells are developed in utero and are capable of producing an inflammatory-type immune response. The results of this study suggest that it may be possible to develop vaccine-induced immunological memory, during pregnancy and specific to the fetus, which would increase immunity in infants during the...
-
News | 2014.06.16
Call for applications: Scientists specialized in Microbiology
Institut Pasteur is seeking to reinforce its position by recruiting outstanding scientists (including clinicians) specialized in microbiology (virologists, bacteriologists). Major areas that we want to strengthen are vector-borne diseases (viral and bacterial), vaccine-preventable diseases (whooping cough, diphtheria, papillomaviruses), anaerobes, antimicrobial drug resistance.
-
Article | 2017.08.07
Anti-Rabies Center - Rabies post-exposure prophylaxis
The Anti-Rabies Center-Rabies post-exposure prophylaxis-attends to anyone who has been in contact with an animal that may transmit rabies, either in France or abroad. Rabies is a deadly disease and treatment needs to be started as soon as possible. The medical team will see any patients at risk, immediately following rabies exposure, or wishing to continue a course of treatment started abroad.
-
Article | 2020.06.22
Deciphering the virus interactions with the entry receptors in human cells, and their potential inhibition
Aim: Researchers will develop and employ a workflow that combines cryogenic light and electron microscopy imaging modalities with computational analysis and data mining to determine high-resolution in-situ structural images of the virus-spike interactions with cell receptors and with the antibodies that abrogate their cell entry. These studies will provide a blueprint for the design of...
-
Article | 2020.08.20
Licensing opportunities
Available TechnologiesIf you are interested in currently available technologies from the Institut Pasteur in 4 main categories (Diagnostic, Therapeutics, Vaccines and Technology), please contact the Business Development teamContact us
-
Document de presse | 2022.07.22
Meningref trial shows better protection against meningococcal infection in hematopoietic stem cell transplant recipients
The team in the Hematology Department at Henri Mondor AP-HP Hospital, coordinated by Dr. Christine Robin, and scientists from the Institut Pasteur (the Invasive Bacterial Infections Unit led by Professor Muhamed-Kheir Taha) recently studied protection against meningococcal infection in patients who had received hematopoietic stem cell transplantation.The results of this trial (NCT03509051),...